A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer-Reference-Cited by-同舟云学术

A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer

Published:2013-09 Issue:5 Volume:12 Page:428-433
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Spratt Daniel E.,Scala Lawrence M.,Folkert Michael,Voros Laszlo,Cohen Gil’ad N.,Happersett Laura,Katsoulakis Evangelia,Zelefsky Michael J.,Kollmeier Marisa A.,Yamada Yoshiya

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference25 articles.

1. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial;Yoshioka;Int J Radiat Oncol Biol Phys,2000

2. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report;Martinez;Int J Radiat Oncol Biol Phys,2001

3. A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer;Corner;Int J Radiat Oncol Biol Phys,2008

4. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy;Ghadjar;Brachytherapy,2009

5. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: A Phase II trial;Barkati;Int J Radiat Oncol Biol Phys,2012

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized Trial Comparing Quality of Life After Low-Dose Rate or High-Dose Rate Prostate Brachytherapy Boost With Pelvic External Beam Radiation Therapy;International Journal of Radiation Oncology*Biology*Physics;2024-09

2. Outcomes of patients with localized prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy boost: A single-center retrospective study;Forum of Clinical Oncology;2024-06-07

3. Treatment planning comparison of high-dose-rate brachytherapy vs. robotic and conventional stereotactic body radiotherapy for ultrahypofractionated treatment of prostate cancer;Physics and Imaging in Radiation Oncology;2023-04

4. Pattern of Radiotherapy Treatment in Low-Risk, Intermediate-Risk, and High-Risk Prostate Cancer Patients: Analysis of National Cancer Database;Cancers;2022-11-09

5. Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?;Radiotherapy and Oncology;2022-04